Tissue15 residues

BPC-157

BPC157

BPC-157 is a synthetic pentadecapeptide studied in tissue-injury models and cultured cells. Published mechanistic findings should be kept separate from claims about human healing.

Reviewed September 2026

Residues
15. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
Average mass
1,419.54 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
pI
4.03 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.

Primary structure

Sequence

N-terminusC-terminus

Peptide. Sequence describes the reference peptide, not a tested supplier lot.

Calculated properties

Calculated from the sequence
FormulaC62H98N16O22
Monoisotopic mass1418.7042 Da
Extinction coefficient at 280 nmNone (no Tyr or Trp)
A280 at 1 mg/mLNot measurable
Residues15
Average mass1,419.54 Da
pI4.03 (theoretical)
Identity
AliasesBPC157
SequenceGEPPPGKPADDAGLV
Research areaTissue

Property basis and sources

These describe the reference compound or formulation, not identification or testing of the supplied lot.

Calculation scope: the stored canonical amino-acid sequence with free N- and C-termini, no other modifications or counterions. This specifies a reference form, not the chemical form or identity of a sold lot.

  • Residues: 15 (calculated). Count of residues in the stored canonical reference sequence; terminal groups are not extra residues. Residues source 1
  • Average mass: 1,419.54 Da (calculated). Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded. Average mass source 1 Average mass source 2 Average mass source 3
  • pI: 4.03 (theoretical) (calculated). Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation. pI source 1 pI source 2

Residue composition

Unique residues
8
Most common
Proline
Nonpolar residues
0
Other classified residues
15

Proline is the most common residue (4). The calculated charge at pH 7 is net negative (-2.01).

Reference scope and linked records

Reference type: Peptide.

This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.

Catalogue context: BPC157. The product retains its own name and specification; this link does not certify equivalence to published study material.

Related references

Sources and their scope

  1. BPC 157 and growth hormone receptor expression in tendon fibroblasts. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
  2. BPC 157 and angiogenesis in muscle and tendon healing. Source for the chemistry or study context discussed above; not an Aminos lot certificate.

Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.

About BPC-157

Identity and context

The selected primary studies examine tendon fibroblasts and muscle or tendon injury models. They provide experimental context for the BPC-157 name, rather than a general-purpose clinical indication. This reference does not equate a sequence record with proof of material purity.

Reference classification

Peptide. The linked catalogue product is BPC157. This reference does not independently authenticate the material supplied.

Storage and handling

Analytical specification

Request identity and purity as separate analytical results. Confirm the complete peptide specification, and distinguish experiments on BPC-157 alone from those on any mixture containing it.

Storage and experimental handling

Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.

Research evidence

Research evidence for this compound
AreaSummaryEvidence
What the source examinesOne study reported increased growth hormone receptor expression in rat tendon fibroblasts. Another compared angiogenesis-related findings in cell culture and injured animals: it did not find a direct angiogenic effect in the cell cultures, while reporting changes in healing tissues. That difference cautions against reducing the literature to a single universal mechanism.Source context
What cannot be inferredThese studies do not establish clinical efficacy in people, and they do not test the catalogue blends. No current lot-specific certificate was available for this reference, so no measured purity percentage is asserted.Evidence limits

References

Sources used for the data on this page, checked September 2026.

  1. BPC 157 and growth hormone receptor expression in tendon fibroblastsPrimary source for the reference discussion; not lot-specific product evidence.
  2. BPC 157 and angiogenesis in muscle and tendon healingPrimary source for the reference discussion; not lot-specific product evidence.

Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.